Register Login

Wave Life Sciences (WVE)

  • Event
  • June 14, 2022, 13:32 UTC

(99% Neutral) WAVE LIFE SCIENCES LTD. (WVE) Provides Update on manager for Wave Life Sciences’ ordinary shares on June 13

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 7:28 a.m.

    📋 WAVE LIFE SCIENCES LTD. (WVE) - Clinical Trial Update

    Filing Date: 2022-06-14

    Accepted: 2022-06-14 09:32:04

    Event Type: Clinical Trial Update

    Event Details:

    Wave Life Sciences (WVE) Announces Clinical Trial Update Wave Life Sciences (WVE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: manager, price
    • Diseases/Conditions: Wave Life Sciences’ ordinary shares on June 13, each pre-funded warrant
    • Collaboration: RA Capital
      • targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Wave Life Sciences
    • CIK: 0001631574
    • Ticker Symbol: WVE
    • Period End Date: 2022-06-14
    • Document Type: 8-K

Search

News categories